Takeda Pharmaceutical Co Ltd ADR Earnings

The next earnings date for Takeda Pharmaceutical Co Ltd ADR is October 30, 2025.

They are scheduled to announce earnings before the market opens that day.

Analyst Estimates of Takeda Pharmaceutical Co Ltd ADR Earnings

Report Date	Estimated Earnings Per Share
10/30/2025	$0.15

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Takeda Pharmaceutical Co Ltd ADR Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
07/30/2025	Before Market	---	---
05/07/2025	Before Market	---	---
01/30/2025	Before Market	$0.05	-92.41%
10/31/2024	Before Market	$29.07	-66.76%
07/31/2024	Before Market	$0.19	---
05/09/2024	Before Market	$-0.01	54.23%
02/01/2024	Before Market	$33.79	31,042.86%
10/26/2023	Before Market	$-15.50	-10,856.42%
07/27/2023	Before Market	$0.20	69.62%
05/22/2023	After Market	$0.07	46.53%
02/02/2023	---	$0.29	3.14%
10/27/2022	Before Market	$0.13	-23.45%
07/28/2022	Before Market	$0.25	7.03%
05/11/2022	Before Market	$-0.03	-144.72%
02/03/2022	Before Market	$0.16	-27.21%
10/28/2021	Before Market	$-0.05	-120.52%
07/30/2021	Before Market	$0.59	77.38%
05/11/2021	Before Market	$0.58	99.86%
02/04/2021	Before Market	$0.40	-12.52%
11/02/2020	After Market	$1.10	-98.93%
07/31/2020	Before Market	$26.47	-74.55%
05/13/2020	Before Market	$0.55	361.90%
02/04/2020	Before Market	$3	-96.00%
11/13/2019	After Market	$0.16	176.19%
07/31/2019	Before Market	$-0.06	67.68%
05/14/2019	Before Market	$-0.62	-72.22%
02/01/2019	Before Market	$0.22	118.60%
10/31/2018	Before Market	$0.27	18.96%
07/31/2018	Before Market	$0.45	44.13%
05/14/2018	Before Market	$-0.31	15.08%
02/01/2018	---	$0.40	---
11/01/2017	---	$0.16	---
07/28/2017	---	$0.84	---
05/10/2017	---	$-0.28	---
02/01/2017	---	$0.24	---
10/27/2016	---	$0.15	---
07/29/2016	---	$0.59	---
05/10/2016	---	$-0.19	---
02/03/2016	---	$0.31	---
10/30/2015	---	$0.15	---
07/30/2015	---	$0.13	---
05/15/2015	---	$-1.20	---
02/05/2015	---	$0.10	---
10/30/2014	---	$0.17	---
08/01/2014	---	$0.21	---
05/08/2014	---	$-0.13	---
02/05/2014	---	$0.29	---
10/31/2013	---	$0.23	---
07/31/2013	---	$0.19	---
05/09/2013	---	$-0.05	---
02/04/2013	---	$0.15	---
10/31/2012	---	$0.26	---
07/30/2012	---	$0.69	---
05/11/2012	---	$-0.29	---
02/01/2012	---	$0.20	---
11/04/2011	---	$0.49	---
07/29/2011	---	$0.59	---
05/11/2011	---	$0.25	---
02/03/2011	---	$0.55	---
10/29/2010	---	$0.60	---
07/30/2010	---	$0.45	---
05/11/2009	---	$0.44	---
11/04/2008	---	$0.39	---
07/31/2008	---	$0.01	---
05/09/2008	---	$0.14	---

More About Takeda Pharmaceutical Co Ltd ADR

Website

https://www.takeda.com

Country

USA

Full Time Employees

47,455

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.

“Takeda Pharmaceutical Co Ltd ADR Earnings” Can Refer to the Takeda Pharmaceutical Co Ltd ADR Earnings Date

Some people say “Takeda Pharmaceutical Co Ltd ADR earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Takeda Pharmaceutical Co Ltd ADR position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Takeda Pharmaceutical Co Ltd ADR Stock on the Earnings Date

If you own Takeda Pharmaceutical Co Ltd ADR stock (TAK) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Takeda Pharmaceutical Co Ltd ADR might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Takeda Pharmaceutical Co Ltd ADR shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Takeda Pharmaceutical Co Ltd ADR Earnings

You can contact us any time if you would like to ask questions about Takeda Pharmaceutical Co Ltd ADR earnings or anything else related to the stock market.